Last updated on August 2020

A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease


Brief description of study

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

Clinical Study Identifier: NCT04232553

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.